(Q46500058)

22 December 2017

title

The case against using 5-aminosalicyclates in Crohn's disease: con. (English)

1 reference

22 December 2017

author name string

Eduard F Stange

series ordinal

1

1 reference

22 December 2017

language of work or name

1 reference

1 June 2005

1 reference

22 December 2017

Inflammatory Bowel Diseases

published in

1 reference

22 December 2017

volume

11

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

613-615

1 reference

22 December 2017

Inflammatory Bowel Disease

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Drug utilization study in patients with Crohn's disease in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Review article: prevention of postsurgical relapse and recurrence in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argument

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

Are claims of equivalency in digestive diseases trials supported by the evidence?☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000160745.09525.74

10.1097/01.MIB.0000160745.09525.74

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017